HERNIA MESH LAWSUIT UPDATE: Transfer of Federal Bard/Davol Hernia Mesh Cases to Ohio

Categories: Hernia Mesh Lawsuits

On August 2, 2018, the Judicial Panel on Multidistrict Litigation (JPML) created a new MDL for the federal lawsuits alleging injury caused by polypropylene hernia mesh products manufactured by C.R. Bard Inc. and subsidiary Davol Inc.  (The alleged injuries include adhesions, damage to organs, inflammatory and allergic responses, foreign body rejection, migration, infections and other injury.) In…

Read More

RECALL OF CERTAIN BLOOD PRESSURE AND HEART MEDICINES CONTAINING VALSARTAN AFTER DETECTION OF CARCINOGEN

Categories: Medication Recall

On July 13, 2018, the U.S. Food and Drug Administration issued an alert of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. According to the FDA, the presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured. Also per the FDA’s latest update today, “Based on records from the manufacturer of the recalled valsartan, some levels of the impurity may have been in the valsartan-containing products for as long as four years.”

On July 13, 2018, the U.S. Food and Drug Administration issued an alert of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. NDMA is classified as…

Read More

BAYER ANNOUNCES IT WILL STOP SELLING ESSURE BIRTH CONTROL IMPLANTS

Categories: Essure Litigation

On Friday, Bayer announced that it would discontinue sales of its controversial Essure birth control implant by the end of the year. The announcement comes amidst thousands of claims brought by injured women alleging that Bayer failed to adequately warn of Essure’s potential dangers and adverse side effects.  The lawsuits also allege that Bayer breached…

Read More

Serious E. Coli Multistate Outbreak: CDC Warns Do Not Eat Romaine Lettuce Unless You Can Confirm It is Not from Yuma, Arizona Growing Region

Categories: Food Safety and Recalls

The list of people infected with the multistate outbreak of Shiga toxin-producing E. coli O157:H7 is quickly growing. Currently, the CDC is reporting that as of April 19, 2018, 53 people in 16 states have been infected, including 31 people who have been hospitalized and five people who have developed a type of kidney failure called hemolytic…

Read More

6TH CIRCUIT HOLDS THAT EMPLOYER UNLAWFULLY DISCRIMINATED AGAINST FIRED TRANSGENDER EMPLOYEE

Categories: Employment Discrimination Law

Recently, the United States Court of Appeals for the Sixth Circuit held in a unanimous decision that discrimination on the basis of an employee’s transgender or transitioning status violates Title VII of the Civil Rights Act of 1964. (Equal Emp’t Opportunity Comm’n v. R.G. & G.R. Harris Funeral Homes, Inc., 2018 WL 1177669 [6th Cir. Mar. 7, 2018]) The case…

Read More

HEART FAILURE FROM DIABETES DRUGS, ONGLYZA & KOMBIGLYZE XR- Federal Cases Centralized in the Eastern District of Kentucky

Categories: Diabetes Drug Lawsuits

On February 2, 2018, the Judicial Panel on Multidistrict Litigation (JPML) centralized federal lawsuits filed by individuals who have suffered heart failure after taking the diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR) in multidistrict litigation (“MDL”) in the U.S. District Court, Eastern District of Kentucky before the Honorable Karen K. Caldwell. Saxagliptin is…

Read More